NeoGenomics Announces Executive Leadership and Board of Directors Succession Plan

NeoGenomics to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring

  • NeoLINK Login
  • Investors
  • Contact Us
Search
LogoNeoLINK Login
Menu
  • Home
  • Providers
    Providers
    • Oncology solutions
      • RaDaR ST MRD
      • PanTracer portfolio
      • Lung cancer
      • Breast cancer
      • Colorectal cancer
      • Gastric cancer
      • Gynecologic cancer
      • Hematologic cancers
    • Pathology solutions
      • Test search
      • Lab services
    • Client support & resources
      • EHR Integrations
      • Certifications & licenses
      • Test requisition forms
      • Pathline clients
  • Biopharma
    Biopharma
    • Biopharma partnerships
    • RaDaR ST for Pharma Partners
    • Oncology data solutions
    • Regulatory support
  • Patients
  • About NeoGenomics
    About NeoGenomics
    • Scientific contributions
    • Trade shows & events
    • Oncology view
    • Careers
    • Privacy
    • Contact us
  • Billing
    Billing
    • For clinicians
    • For patients
    • Financial assistance
    • Pay your bill online
  • Test Search
  • Investors
Test Search
Skip to main content Skip to section navigation Skip to footer
NeoGenomics, Inc. IR Overview
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report

Press Releases

Investors News & Events Press Releases
Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Literature
    • Email Alerts
  • Company Info
    • Overview
    • Executive Team
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Info
    • Quote
    • Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • CSR
    • 2025 report
    • Inaugural Report
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Literature
  • Email Alerts
Jun 2, 2020 4:26 pm EDT
NeoGenomics To Virtually Present At The Raymond James Human Health Innovation Conference
Jun 1, 2020 4:05 pm EDT
NeoGenomics To Virtually Participate In Fireside Chat At The 40th Annual William Blair Growth Stock Conference
May 26, 2020 7:20 am EDT
NeoGenomics To Virtually Participate In 17th Annual Craig-Hallum Institutional Investor Conference
May 26, 2020 5:00 am EDT
NeoGenomics Enters Strategic Collaboration with Inivata to Commercialize InVisionFirst(R)-Lung Liquid Biopsy Test
May 11, 2020 4:05 pm EDT
NeoGenomics To Virtually Participate In Fireside Chat At BofA Securities 2020 Health Care Conference
May 5, 2020 8:00 am EDT
NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients
Apr 30, 2020 6:00 am EDT
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Apr 29, 2020 5:20 pm EDT
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
Apr 28, 2020 7:00 am EDT
NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter
Apr 9, 2020 7:00 am EDT
NeoGenomics Provides COVID-19 Business Update
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • …
  • Page 34
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • rss_feedRSS News Feed
  • account_treeSitemap
©2026 NeoGenomics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences